NCT03389893: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03389893 |
|---|---|
| Title | Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis, Dupilumab Study |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 25, 2018 |
| Completion date | April 3, 2020 |
| Required reporting date | April 3, 2021, midnight |
| Actual reporting date | April 2, 2021 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |